The development of central pontine myelinolysis was studied in rats. Severe hyponatraemia was induced using vasopressin tannate and 2.5% dextrose in water and then rapidly corrected with hypertonic saline alone, hypertonic saline and dexamethasone simultaneously, or hypertonic saline plus dexamethasone 24 h later. The permeability of the blood-brain barrier was evaluated using the extravasation of Evans blue dye and the expression of inducible nitric oxide synthase (iNOS) in the brain was examined using Western blot analysis. Histological sections were examined for demyelinating lesions. In rats receiving hypertonic saline alone, Evans blue dye content and expression of iNOS began to increase 6 and 3 h, respectively, after rapid correction of hyponatraemia and demyelinating lesions were seen. When dexamethasone was given simultaneously with hypertonic saline, these increases were inhibited and demyelinating lesions were absent. These effects were lost if dexamethasone injection was delayed. Disruption of the blood-brain barrier and increased iNOS expression may be involved in the pathogenesis of central pontine myelinolysis, and early treatment with dexamethasone may help prevent the development of central pontine myelinolysis.
Introduction
Central pontine myelinolysis (CPM) is a serious condition characterized by demyelination in the pons; it is usually precipitated by the rapid correction of hyponatraemia and is often associated with chronic disease or alcoholism. 1 -4 Treatment is symptomatic and the prognosis is very poor. Prevention is therefore of the utmost importance. The pathogenetic processes involved are unclear, but various studies have demonstrated that glucocorticoids are effective in the treatment of some demyelinating diseases such as multiple sclerosis 5, 6 and may therefore also be of use in the prevention of CPM. In this study, we explored the pathogenesis of CPM and examined the effect of dexamethasone treatment using a rat model.
Materials and methods

ANIMALS
Male Sprague-Dawley rats with a body weight of 200 -250 g (Shanghai Experimental Animal Centre, Chinese Academy of Sciences, Pathogenesis and prevention of central pontine myelinolysis in rats Shanghai, China) were housed in a standard animal facility on a 12 h light/12 h dark cycle. Food and water were freely available. All procedures were performed in accordance with the Animal Care Guidelines of Zhejiang University, which conform to the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Ethics approval was given by the College of Medicine, Zhejiang University, Zhejiang, China.
PROTOCOL TO PRODUCE CENTRAL PONTINE MYELINOLYSIS
Rat CPM models were produced using rapid correction of hyponatraemia. First, hyponatraemia was induced by a subcutaneous injection of 1 unit of vasopressin tannate in oil (Shanghai No.1 Biochemical and Pharmaceutical Company, Shanghai, China) per 100 g body weight and an intraperitoneal injection of 2.5% dextrose in water equal to 5% of body weight twice daily (at 8.00 and 16.00 h) on day 1 and day 3 and once (at 8.00 h) on day 2. Secondly, the hyponatraemia was rapidly corrected by the administration of a bolus intraperitoneal injection of 1 mol/l hypertonic saline (2 ml/100 g body weight) on day 4 (at 8.00 h).
All injections were performed under light ethyl ether anaesthesia.
EXPERIMENTAL GROUPS
In each of the two parts of the study, animals were divided into four groups; treatments were the same in each part of the study. In group A, CPM was induced as described above. In group B, CPM was induced as above, and a bolus intramuscular injection of dexamethasone (5 mg/kg body weight) was given simultaneously with the injection of hypertonic saline on day 4. In group C, CPM was induced as above, and a bolus intramuscular injection of dexamethasone (5 mg/kg body weight) was given 24 h after the injection of hypertonic saline. In group D, rats were anaesthetized with ether and received sham subcutaneous and intraperitoneal injections of isotonic saline.
SERUM SODIUM CONCENTRATION ANALYSIS
Blood samples (0.5 -0.7 ml) were removed from the tail under light ether anaesthesia on day 0 (baseline), at the time of the hypertonic saline (or sham) injection and 6, 12, 24 and 36 h later. The serum sodium concentration in the samples was measured using a Clinical Analyzer (Hitachi, Tokyo, Japan).
HISTOLOGICAL EXAMINATION OF BRAIN TISSUE
In this part of the study, rats were subjected to the protocol to produce CPM as described above and all animals surviving to day 8 were killed under deep ether anaesthesia. The brains were removed from the cord at the upper cervical level and fixed in 10% buffered formaldehyde for 24 h. They were then dehydrated and embedded in paraffin. Sections were stained for myelin using eriochrome cyanine R (Sigma, St Louis, Missouri, USA).
EVALUATION OF BLOOD-BRAIN BARRIER PERMEABILITY
In the study of blood-brain barrier permeability and the expression of inducible nitric oxide synthase (iNOS; see next section), rats were subjected to the same protocol to produce CPM as described above, and groups of animals were killed 3, 6, 12, 24 and 36 h after the injection of hypertonic saline. The permeability of the blood-brain barrier was investigated using extravasation of Evans blue dye (Sigma). Evans blue (2% in saline, 4 ml/kg) was injected intravenously; 30 min later the chest was opened and the left ventricle was Pathogenesis and prevention of central pontine myelinolysis in rats perfused with saline until colourless perfusion fluid was obtained from the right atrium. The brain was then removed, weighed and soaked in 4 ml formamide fluid (Sigma) for 24 h at 45°C. The supernatant was analysed spectrophotometrically at 632 nm and the content of Evans blue, expressed per gram of tissue, was calculated using a linear standard curve derived from known amounts of dye.
WESTERN BLOT ANALYSIS OF INDUCIBLE NITRIC OXIDE SYNTHASE
Inducible nitric oxide synthase was measured in brain tissue lysates. Samples containing 50 µg protein were separated using 8% sodium dodecyl sulphate-polyacrylamide gel electrophoresis and the separated proteins were transferred onto nitrocellulose membranes. After blocking, the membranes were incubated with a 1:1000 dilution of goat anti-iNOS antibody or goat anti-actin antibody (Santa Cruz Biotechnology, Santa Cruz, California, USA) overnight with gentle agitation at 4°C. The blots were then incubated with a 1:2000 dilution of horseradish peroxidase-conjugated anti-goat immunoglobulin (Chemicon, Temecula, California, USA) for 2 h, developed using an electrochemiluminescence detection reagent and exposed using the Kodak Image 2000R System (Kodak, Rochester, New York, USA).
STATISTICAL ANALYSIS
Results were expressed as the mean ± SE. One-way analysis of variance and Fisher's exact probability test were used for statistical analysis. A P-value < 0.05 was considered to be statistically significant.
Results
A total of 66 rats were used for the histological examination of the brain. Groups A, B and C consisted of 20 rats each, whereas group D, the sham injection group, consisted of six rats. To study the permeability of the blood-brain barrier and iNOS expression, five to eight animals were killed in each group 0, 3, 6, 12, 24 and 36 h after the injection of hypertonic saline.
In group A, four rats died during the induction of hyponatraemia. After the injection of hypertonic saline, four rats developed paralysis and subsequently died. In group B, eight rats died during the induction of hyponatraemia, but no rats were paralysed or died after the injection of hypertonic saline. In group C, nine rats died during the induction of hyponatraemia and four were paralysed after the injection of hypertonic saline, of which three died.
SERUM SODIUM CONCENTRATIONS
The serum sodium concentrations in the four groups at the different time points are shown in Table 1 . Administration of subcutaneous vasopressin tannate and intraperitoneal 2.5% dextrose in water successfully induced severe hyponatraemia in the three experimental groups (A, B and C). The serum sodium concentration increased rapidly after the bolus injection of hypertonic saline, returning to normal levels within 24 h. There was no significant difference between the sodium levels in group B and those in group A at equivalent time points, suggesting that the injection of dexamethasone with the hypertonic saline in group B did not affect the changes in serum sodium concentration.
HISTOLOGICAL EXAMINATION OF BRAIN TISSUE
In group A, 12 surviving rats were killed for histological examination of the brain; demyelinating lesions were found in the thalamus, brainstem and corpus striatum in eight of the 12 (66.7%) (Fig. 1A) . In group B no demyelinating lesions were found in the Q-H Ke, T-B Liang, J Yu et al. Values are mean ± SE. a P < 0.01 versus baseline and group D value at same time point; b P < 0.01 versus 0 h; c difference from baseline and group D value at same time point not significant. n indicates the number of rats surviving until day 8.
Pathogenesis and prevention of central pontine myelinolysis in rats
Serum sodium levels (mmol/l) in rats with induced hyponatraemia at different time points after injection of hypertonic saline alone (group A), hypertonic saline plus dexamethasone (group B) or hypertonic saline plus dexamethasone 24 h later (group C) and control rats given sham injections of isotonic saline (group D)
12 survivors ( Fig. 1B) and in group C demyelinating lesions were found in six of the eight survivors (75%) (Fig. 1C ). The morbidity rates in groups A and C were not significantly different, suggesting that early treatment with dexamethasone could prevent the appearance of demyelinating lesions, whereas delayed treatment with dexamethasone did not have this effect. No demyelinating lesions were found in group D (Fig. 1D ). 
BLOOD-BRAIN BARRIER PERMEABILITY
Evans blue content in brain tissue was used as an index of the permeability of the blood-brain barrier. At the time of the hypertonic saline injection (0 h), the Evans blue content in groups A, B and C was 1.22 ± 0.29, 1.36 ± 0.14 and 1.27 ± 0.17 µg/g brain tissue, respectively. These values were not significantly different when compared with that of group D (1.22 ± 0.14 µg/g brain tissue). The Evans blue content in group A began to increase by 6 h after correction of the hyponatraemia, peaking at 24 h (Fig. 2) . This increase in Evans blue content was significantly inhibited in group B compared with group A (P < 0.01) 6, 12, 24 and 36 h after correction of the hyponatraemia (Fig. 2) . Although the Evans blue content in group B increased slightly after the injection of hypertonic saline, the increase was not significant compared with the content at 0 h (Fig 2) .
The Evans blue content in group C was similar to that in group A. The permeability of the blood-brain barrier did not increase in group D.
EXPRESSION OF INDUCIBLE NITRIC OXIDE SYNTHASE
The expression of iNOS in group D remained at a low level. After the rapid correction of hyponatraemia, expression of iNOS in group A began to increase by 3 h after the injection of hypertonic saline and remained at a higher level up to 36 h (Fig. 3) . Early treatment with dexamethasone in group B was associated with reduced expression of iNOS (Fig. 3) . The expression of iNOS in group C was the same as in group A.
Discussion
Central pontine myelinolysis, as described in humans, is characterized by a symmetrical focus of myelin destruction at the centre of the basis pontis that often extends from the Time after injection of hypertonic saline (h) Evans blue dye content (µg/g brain tissue) Pathogenesis and prevention of central pontine myelinolysis in rats midbrain to nerves in the lower pons. It is often precipitated by rapid correction of hyponatraemia. 7 Before the advent of magnetic resonance imaging, early diagnosis was difficult. 8 Even today, little is known about CPM.
In the present study, demyelination, confirmed by myelin staining, was successfully induced in rats by the rapid correction of hyponatraemia. Disruption of the blood-brain barrier seemed to play an important role. The Evans blue dye content of brain tissue is an index of the permeability of the blood-brain barrier; an increase in Evans blue content suggests that the integrity of the blood-brain barrier is disrupted. When the rats had severe hyponatraemia, the Evans blue content remained at normal levels, but rapid correction of the hyponatraemia with hypertonic saline resulted in an acute osmotic change that led to the osmotic opening of the blood-brain barrier, with a resulting substantial increase in Evans blue content after 6 h. The blood-brain barrier is a very important mechanism in the brain; disruption of the barrier can lead to myelinotoxic factors entering the brain tissue and demyelination may occur. In the present study, there was a period of approximately 6 h between correction of the hyponatraemia and significant disruption of the blood-brain barrier. Thus, measures taken during this time to protect the blood-brain barrier may be effective in preventing demyelination.
Recently, the role of iNOS has been increasingly studied. 9,10 Liu et al. 11 reported that iNOS was associated with the disruption of the blood-brain barrier in multiple sclerosis lesions. In the present study, we observed the changes in iNOS expression during the development of CPM. Following rapid correction of hyponatraemia, expression of iNOS began to increase after 3 h and remained at a relatively high level up to 36 h. In normal brain, iNOS is expressed at a low level. Increased expression of iNOS is associated with excessive production of endogenous nitric oxide, 12 which could dilate the gaps between endothelial cells and aggravate the disruption of the blood-brain barrier. It could also induce the production of oxygen-derived free radicals, which are directly neurotoxic. 13 These effects could induce or aggravate the injuries occurring in CPM. 
Pathogenesis and prevention of central pontine myelinolysis in rats
The prognosis of CPM is very poor; few people survive. Preventive measures are therefore of the utmost importance. In the present study, dexamethasone given at the time of rapid correction of hyponatraemia was investigated as a preventive strategy in CPM. We found that early use of dexamethasone inhibited both disruption of the blood-brain barrier and the increase in iNOS expression, and demyelinating lesions were not seen in these animals. However, if administration of dexamethasone was delayed until 24 h after correction of the hyponatraemia, its preventive effect was lost. The time of dexamethasone administration is therefore very important in the prevention of CPM: to prevent the occurrence of demyelination, dexamethasone should be given before the disruption of the blood-brain barrier. Once disruption of the blood-brain barrier has occurred, myelinotoxic factors will have begun to damage the brain tissue and dexamethasone will not be able to prevent the demyelination process.
In many clinical cases, CPM is caused iatrogenically by the too rapid correction of hyponatraemia; 14 the change in sodium concentration should not exceed 12 mmol/l within 24 h. 14, 15 If correction of hyponatraemia occurs too rapidly, the early use of dexamethasone may be effective in preventing the development of CPM.
